You will handle the computed tomography procedure and create much more detailed images with X-rays"

The hepato-bilio-pancreatic area is presented as a vital area for the functioning of the body, but its anatomy is complex and sometimes its anatomical evaluation by radiological and endoscopic tests is difficult. Eighty percent of hepatobiliopancreatic surgeries are performed by minimally invasive surgery, resulting in less postoperative pain, less blood loss and shorter hospital stay. To this end, it is vital for specialists to be at the forefront of the most innovative procedures, providing the most accurate diagnoses and applying the safest treatments for patients.

Surgeons face the constant challenge of combining the updating of their knowledge with the improvement of their technical skills. In view of this, TECHhas created a complete Professional master’s degree, through which students will have access to the most updated contents in pancreatic, hepatic and biliary pathology. Throughout this study plan, emerging technologies (abdominal ultrasound or magnetic resonance imaging), used for diagnostic imaging of hepatic focal lesions will be addressed.

Likewise, the classification of less frequent liver tumors (such as hepatoblastomas) will be studied in depth in order to contribute to early diagnosis and promote scientific research. The most up-to-date procedures, such as the laparoscopic technique and robotic surgery, will also be discussed. In this sense, these contemporary therapeutic approaches will enable graduates to make informed decisions and consider multidisciplinary treatment options.
In addition, the methodology of this program reinforces its innovative character. TECHoffers a 100% online educational environment, tailored to the needs of busy professionals seeking to advance their careers. It also employs the Relearning methodology, based on the repetition of key concepts to fix knowledge and facilitate learning. In this way, the combination of flexibility and a robust pedagogical approach makes it highly accessible.

You will diagnose the least common epithelial tumors with the best digital university in the world, according to Forbes”

This Professional master’s degree in Hepatobiliopancreatic Surgery  contains the most complete and up-to-date scientific program on the market. The most important features include: 

• The development of practical cases presented by experts in Hepatobiliopancreatic Surgery
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Practical exercises where the process of self-assessment can be used to improve learning
• Its special emphasis on innovative methodologies
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

You will achieve your goals thanks to TECH's didactic tools, including explanatory videos and interactive summaries"

The program’s teaching staff includes professionals from the field who contribute their work experience to this educational program, as well as renowned specialists from leading societies and prestigious universities.

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive education programmed to learn in real situations.

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise during the academic year For this purpose, the students will be assisted by an innovative interactive video system created by renowned and experienced experts.

You will perform the most complete ultrasound scans with the help of ultrasonic probes. And in only 12 months!"

You will detect upper gastrointestinal bleeding in order to apply the most appropriate primary prophylaxis, according to your personal needs"

This program will offer students the most updated contents on pancreatic and hepatic pathology, as well as biliary tract. The syllabus will allow specialists to make a differential diagnosis, taking into account the typology of the patients, both in urgent and programmed surgery. The didactic materials will delve into the surgical anatomy of the liver, analyzing the methods for the management of bleeding, such as transfusions. Likewise, the different benign liver tumors will be addressed, so that students understand their causes, symptoms and diagnoses. In addition, an update on the surgical treatment of portal hypertension will be offered in order to prevent complications.

A syllabus that contains the most complete and updated scientific program on the market. Enroll now!”

Module 1. Surgical anatomy of the liver

1.1. Liver Anatomy

1.1.1. General Aspects
1.1.2. Embryonic development of the liver of the bile duct
1.1.3. Conclusions

1.2. Anatomical relationships of the liver

1.2.1. Superior relationships
1.2.2. Anterior relationships
1.2.3. Lateral Relationships

1.3. Hepatic vascularization

1.3.1. Definition
1.3.2. Types
1.3.3. Conclusions

1.4. Anatomy of the biliary tree

1.4.1. Organs
1.4.2. Hepatic ducts
1.4.3. Conclusions

1.5. Hepatic segmentation

1.5.1. Anatomical segmentation
1.5.2. Division into Eight Segments
1.5.3. Clinical Significance

1.6. Ultrasound exploration of the hepatic anatomy

1.6.1. Position of the Patient
1.6.2. Ultrasonic probe
1.6.3. Exploration of the liver

1.7. Type of hepatic anatomical approaches

1.7.1. Hepatectomy
1.7.2. Segmentectomy
1.7.3. Wedge resection

1.8. Management of bleeding in liver surgery

1.8.1. Use of hemostatics and sealants
1.8.2. Suture technique
1.8.3. Blood transfusion

1.9. Techniques of vascular control in liver surgery

1.9.1. Main Techniques
1.9.2. Most used techniques
1.9.3. Conclusions

1.10. Hemostatic agents in liver surgery

1.10.1. Hemostatic sponges
1.10.2. Absorbable gelatins
1.10.3. Tissue adhesives

Module 2. Hepatic Pathology

2.1. Pre-Operative Study

2.1.1. Medical History
2.1.2. Hepatic Function Tests (LFTs)
2.1.3. Other Tests

2.2. Liver function

2.2.1. Key liver functions
2.2.2. Bile production
2.2.3. Conclusions

2.3. Classification of liver diseases

2.3.1. Infectious
2.3.2. Metabolic
2.3.3. Genetics

2.4. Pre-operative and intraoperative diagnostic methods for liver disease

2.4.1. Imaging tests
2.4.2. Hepatic biopsy
2.4.3. Hepatic scintigraphy
2.4.4. Other Tests

2.5. Study of Liver Function

2.5.1. Markers
2.5.2. Coagulation time
2.5.3. Laboratory Tests

2.6. Hepatic volumetry

2.6.1. Computed Tomography (CT) and Magnetic Resonance Imaging (MRI)
2.6.2. Hepatic Ultrasound Scan
2.6.3. Hepatic scintigraphy

2.7. Diagnostic imaging of focal hepatic lesions in patients with chronic liver disease

2.7.1. Abdominal ultrasound
2.7.2. Computed Tomography (CT)
2.7.3. Magnetic Resonance Imaging (MRI)

2.8. Incidental hepatic lesions

2.8.1. Differential Diagnosis
2.8.2. Types of Lesions
2.8.3. Treatment

2.9. Interventional radiology in the management of liver disease

2.9.1. Image-guided liver biopsy
2.9.2. Percutaneous drainage of hepatic abscesses
2.9.3. Transarterial Embolization (TAE) and Chemoembolization (TACE)

2.10. Anesthetic management in hepatic surgery

2.10.1. Properative Evaluation
2.10.2. Hemodynamic control
2.10.3. Coagulation management

Module 3. Benign Liver Disease

3.1. Classification of benign hepatic tumors

3.1.1. Hepatic hemangiomas
3.1.2. Focal Nodular Hyperplasia (FNH)
3.1.3. Hepatic adenomas

3.2. Benign hepatocellular epithelial tumors

3.2.1. Hepatocellular adenoma
3.2.2. Focal Nodular Hyperplasia (FNH)
3.2.3. Nodular Regeneration Focus (NRF)

3.3. Benign cholangiocellular epithelial tumors

3.3.1. Biliary papilloma
3.3.2. Biliary adenoma
3.3.3. Ductopenia

3.4. Benign mesenchymal tumors

3.4.1. Hepatic fibroma
3.4.2. Hepatic leiomyoma
3.4.3. Conclusions

3.5. Pyogenic Hepatic Abscesses

3.5.1. Causes and Risk Factors
3.5.2. Symptoms
3.5.3. Diagnosis

3.6. Amoebic Liver Abscesses

3.6.1. Causes
3.6.2. Symptoms
3.6.3. Diagnosis

3.7. Hepatic hydatidosis

3.7.1. Causes
3.7.2. Symptoms
3.7.3. Diagnosis

3.8. Complications of hepatic abscesses

3.8.1. Rupture of the abscess
3.8.2. Fistula formation
3.8.3. Other Complications

3.9. Simple liver cysts

3.9.1. Polycystic liver cyst
3.9.2. Diagnosis
3.9.3. Treatment

3.10. Other benign liver lesions

3.10.1. Hamartoma
3.10.2. Inflammatory pseudotumor
3.10.3. Other Lesions

Module 4. Malignant Liver Disease

4.1. Malignant Liver Disease

4.1.1. Main Diseases
4.1.2. Risk Factors
4.1.3. Lifestyle

4.2. Hepatocellular Carcinoma

4.2.1. Risk Factors
4.2.2. Symptoms
4.2.3. Diagnosis

4.3. Intrahepatic Cholangiocarcinoma

4.3.1. Risk Factors
4.3.2. Symptoms
4.3.3. Diagnosis

4.4. Other less frequent epithelial tumors

4.4.1. Hepatic cystadenocarcinoma
4.4.2. Fibrolamellar carcinoma
4.4.3. Hepatoblastoma

4.5. Mesenchymal Tumors

4.5.1. Undifferentiated embryonal sarcoma
4.5.2. Epidermoid hemangioendothelioma
4.5.3. Angiosarcoma. Lymphoma

4.6. Hepatic metastases of colorectal cancer

4.6.1. Risk Factors
4.6.2. Symptoms
4.6.3. Diagnosis

4.7. Clinical scenarios and factors to be taken into account for treatment choice

4.7.1. Causes
4.7.2. Control of Risk Factors
4.7.3. Possible treatments

4.8. Surgical strategies for malignant hepatic pathology

4.8.1. Hepatic resection
4.8.2. Liver transplantation
4.8.3. Others

4.9. Hepatic metastases of colorectal cancer and neuroendocrine tumors

4.9.1. Risk Factors
4.9.2. Symptoms
4.9.3. Treatment

4.10. Liver metastases not from colorectal cancer or neuroendocrine tumors

4.10.1. Risk Factors
4.10.2. Symptoms
4.10.3. Treatment

Module 5. Hepatic and Duodecenopancreatic Trauma

5.1. Mechanism of injury in hepatic traumatism

5.1.1. Degrees of injury
5.1.2. Injury management
5.1.3. Conclusions

5.2. Evaluation, exploration and classification of hepatic traumatism

5.2.1. Assessment
5.2.2. Exploration
5.2.3. Classification

5.3. Conservative management of hepatic trauma

5.3.1. Types of Lesions
5.3.2. Strategies
5.3.3. Conclusions

5.4. Surgical management of hepatic traumatism

5.4.1. Type of lesions
5.4.2. Strategy
5.4.3. Conclusions

5.5. Injuries to the vena cava and suprahepatic veins in liver trauma

5.5.1. Cava Vein
5.5.2. Suprahepatic veins
5.5.3. Diagnosis and Management

5.6. Mechanism of injury in duodenal and pancreatic traumatism

5.6.1. Trauma
5.6.2. Associated injuries
5.6.3. Treatment

5.7. Evaluation, examination and classification of duodenal and pancreatic trauma

5.7.1. Assessment
5.7.2. Exploration
5.7.3. Classification

5.8. Diagnosis of duodenal and pancreatic trauma

5.8.1. Clinical Assessment
5.8.2. Diagnostic Tests
5.8.3. Treatment

5.9. Treatment of duodenal and pancreatic traumatism

5.9.1. Duodenal trauma
5.9.2. Pancreatic trauma
5.9.3. Special considerations

5.10. Complications of duodenal and pancreatic traumatism

5.10.1. Management of complications
5.10.2. Evaluation of complications
5.10.3. Conclusions

Module 6. Study and Diagnosis of the Biliary Tract

6.1. Surgical and vascular anatomy of the biliary tract

6.1.1. Liver
6.1.2. Gallbladder
6.1.3. Cystic duct

6.2. Physiology of bile

6.2.1. Production
6.2.2. Storage
6.2.3. Functions

6.3. Pathophysiology of the gallbladder and biliary tract

6.3.1. Calculations
6.3.2. Tumours
6.3.3. Others

6.4. Clinical history, laboratory tests in the patient with biliary pathology

6.4.1. Medical history
6.4.2. Risk Factors
6.4.3. Conclusions

6.5. Imaging study of the biliary tract

6.5.1. Abdominal ultrasound
6.5.2. Cholangiography by Magnetic Resonance (MRCP)
6.5.3. Abdominal Computed Tomography (CT)

6.6. Colelitiasis

6.6.1. Coledocolitiasis
6.6.2. Causes
6.6.3. Symptoms

6.7. Endoscopic treatment of choledocholithiasis

6.7.1. Endoscopic Retrograde Endoscopic Cholangiopancreatography (ERCP)
6.7.2. Echoendoscopy
6.7.3. Others

6.8. Interventional radiology in the diagnosis of biliary tract pathology

6.8.1. Transhepatic Percutaneous Transhepatic Cholangiography (TPC)
6.8.2. Magnetic Resonance Cholangiography (MRCP) with MRI Cholangiography
6.8.3. Endoscopic Retrograde Endoscopic Cholangiopancreatography (ERCP)

6.9. Surgical management of lithiasic pathology of the biliary tract

6.9.1. Description
6.9.2. Advantages
6.9.3. Procedures

6.10. New therapeutic approaches to biliary tract lithiasic pathology

6.10.1. Laparoscopic approach
6.10.2. Robotic Surgery
6.10.3. Others

Module 7. Pancreatic Disease

7.1. Pancreas Anatomy

7.1.1. Location
7.1.2. Divisions of the pancreas
7.1.3. Relationship with other organs

7.2. Surgical anatomy of the pancreas

7.2.1. Head
7.2.2. Body
7.2.3. Tail

7.3. Embryology of the pancreas

7.3.1. Initial development
7.3.2. Formation of the parts
7.3.3. Conclusions

7.4. Vascularization and venous drainage

7.4.1. Pancreatic arteries
7.4.2. Accessory pancreatic arteries
7.4.3. Drainages

7.5. Lymphatic drainage (lymph node stations)

7.5.1. Peripancreatic lymph node station
7.5.2. Splenic Hilum Lymph Nodal Station
7.5.3. Hepatic Hilum Nodal Station

7.6. Pancreatic physiology

7.6.1. Exocrine function of the pancreas
7.6.2. Endocrine Function of the Pancreas
7.6.3. Regulation of the endocrine function

7.7. Regulation of pancreatic secretion

7.7.1. Neuronal stimulation
7.7.2. Hormonal stimulus
7.7.3. Negative feedback mechanisms

7.8. Medical History

7.8.1. Physical Examination
7.8.2. Complementary Tests
7.8.3. Others

7.9. Imaging studies of pancreatic pathology

7.9.1. Abdominal Computed Tomography (CT)
7.9.2. Magnetic Resonance Imaging (MRI) of the Pancreas
7.9.3. Abdominal ultrasound

7.10. Echoendoscopy in the diagnosis of pancreatic disease

7.10.1. Detailed visualization of the pancreas
7.10.2. Evaluation of pancreatic tumors
7.10.3. Detection of small lesions

Module 8. Benign Pathology of the Bile Duct and Pancreas

8.1. Lithiasic pathology

8.1.1. Cholecystitis
8.1.2. Cholangitis
8.1.3. Diagnosis and Treatment

8.2. Latrogenic lesions of the biliary tract

8.2.1. Cholecystectomy
8.2.2. Liver Surgery
8.2.3. Others

8.3. Obstructive jaundice

8.3.1. Causes
8.3.2. Symptoms
8.3.3. Treatment

8.4. Choledochal cysts

8.4.1. Types
8.4.2. Causes
8.4.3. Symptoms

8.5. Acute Pancreatitis

8.5.1. Classification
8.5.2. Nomenclature
8.5.3. Treatment

8.6. Management of acute pancreatitis

8.6.1. Hospitalization
8.6.2. Pain Management
8.6.3. Hydration

8.7. Chronic Pancreatitis

8.7.1. Types
8.7.2. Causes
8.7.3. Symptoms

8.8. Management of Chronic Pancreatitis

8.8.1. Supplements
8.8.2. Diet
8.8.3. Complications

8.9. Pancreatic Cystic Tumors

8.9.1. Types
8.9.2. Causes
8.9.3. Symptoms

8.10. Surgical indications for pancreatic cystic tumors

8.10.1. Size
8.10.2. Features
8.10.3. Tumor location

Module 9. Malignant Pathology of the Bile Duct and Pancreas

9.1. Pancreatic ductal adenocarcinoma

9.1.1. Features
9.1.2. Symptoms
9.1.3. Treatment

9.2. Classification of ductal adenocarcinoma according to resectability

9.2.1. Types
9.2.2. Causes
9.2.3. Conclusions

9.3. Multidisciplinary treatment of adenocarcinoma of the pancreas

9.3.1. Multidisciplinary team
9.3.2. Initial evaluation and staging
9.3.3. Surgery

9.4. Surgical Techniques

9.4.1. Cephalic duodenopancreatectomy
9.4.2. Corporocaudal splenopancreatectomy
9.4.3. Cephalic pancreatectomy

9.5. Anatomopathologic study of the pancreatectomy specimen

9.5.1. Obtaining the specimen
9.5.2. Fixation and processing
9.5.3. Histological sections

9.6. Adenocarcinoma of the gallbladder

9.6.1. Description
9.6.2. Staging of adenocarcinoma of the gallbladder
9.6.3. Conclusions

9.7. Treatment of adenocarcinoma of the gallbladder

9.7.1. Surgery
9.7.2. Chemotherapy
9.7.3. Radiotherapy

9.8. Extrahepatic cholangiocarcinoma

9.8.1. Description
9.8.2. Diagnosis of extrahepatic cholangiocarcinoma
9.8.3. Conclusions

9.9. Classification of extrahepatic cholangiocarcinoma

9.9.1. Types
9.9.2. Symptoms
9.9.3. Risk Factors

9.10. Treatment of extrahepatic cholangiocarcinoma

9.10.1. Surgery
9.10.2. Chemotherapy
9.10.3. Radiotherapy

Module 10. Surgery for portal hypertension

10.1. Pathophysiology of portal hypertension

10.1.1. Obstruction of blood flow
10.1.2. Increased resistance to flow
10.1.3. Development of portosystemic collaterals

10.2. Etiology

10.2.1. Classification
10.2.2. Hepatic Cirrhosis
10.2.3. Chronic Hepatitis

10.3. Primary prophylaxis of esophageal variceal bleeding

10.3.1. Treatment of the underlying cause
10.3.2. Beta-Blockers
10.3.3. Endoscopic sclerotherapy

10.4. Secondary prophylaxis of bleeding from esophageal varices

10.4.1. Beta-Blockers
10.4.2. Endoscopic sclerotherapy or elastic ligation
10.4.3. Development of continuous monitoring plans

10.5. Treatment of acute esophageal variceal hemorrhage

10.5.1. Stabilization of the Patient
10.5.2. Fluid Therapy and Transfusions
10.5.3. Pharmacological Therapy

10.6. Portosystemic shunts

10.6.1. Procedure
10.6.2. Objectives
10.6.3. Indications

10.7. Devascularization procedures

10.7.1. Selective devascularization
10.7.2. Splenic devascularization
10.7.3. Gastric devascularization

10.8. Surgical treatment of portal hypertension

10.8.1. Transjugular Intrahepatic Portosystemic Intrahepatic Shunt (TIPS)
10.8.2. Surgical Portosystemic Surgical Portosystemic Bypass
10.8.3. Splenectomy

10.9. Postoperative care in the surgery of the PHT

10.9.1. Continuous Monitoring
10.9.2. Care
10.9.3. Pain Management

10.10. Outcomes of portal hypertension surgery

10.10.1. Reduction of portal pressure
10.10.2. Prevention of complications
10.10.3. Symptom improvement

With the Relearning system you will integrate all the concepts in a natural and progressive way"